Papers

Spread of bloodborne viruses among Australian prison entrants

^a Epidemiology and International Health Unit, Macfarlane Burnet Centre of Medical Research, PO Box 65, Fairfield, Victoria 3078, Australia, ^b Pentridge Hospital, Her Majesty's Prison, Coburg, Victoria 3058, Australia, ^c Virology Department, Fairfield Hospital, PO Box 65, Fairfield, Victoria 3078, Australia

Correspondence to: Dr Crofts.

Abstract

Objectives: To assess spread of bloodborne viruses among prison entrants in Victoria, Australia.
Design: Voluntary confidential testing of all prison entrants for markers of exposure to bloodborne viruses with collection of minimal data on demography and risk factors over 12 months.
Setting: Her Majesty's Prisons, Pentridge and Fairlea, Victoria, Australia.
Subjects: 3429 male and 198 female prison entrants (>99% of all prison entrants); 344 entered prison and were tested more than once.
Main outcome measures: Prevalence and incidence of antibodies to HIV, hepatitis B, and hepatitis C viruses, and minimal data on risk factors.
Results: 1562 (46%) gave a history of use of injected drugs, 1171 (33%) had antibody to hepatitis B core antigen, 1418 (39%) were anti-hepatitis C positive including 914 (64%) of the men who injected drugs, 91 (2.5%) were positive for hepatitis B surface antigen, and 17 (0.47%) were positive for antibody to HIV. Incidence rates for infection with hepa
Conclusions: Hepatitis B and C are spreading rapidly through some populations of injecting drug users in Victoria, particularly among men aged less than 30 years at risk of imprisonment in whom rates of spread are extreme; this group constitutes a sizeable at risk population for spread of HIV. This spread is occurring in a context of integrated harm reduction measures outside prisons for prevention of viral spread but few programmes within or on transition from prisons; it poses an urgent challenge to these programmes.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Chong, V. H. (2008). Screening blood-borne virus among incarcerated inmates. Int J STD AIDS 19: 795-795 [Full text]  
• Mahto, M., Zia, S. (2008). Measuring the gap: from Home Office to the National Health Service in the provision of a one-stop shop sexual health service in a female prison in the UK. Int J STD AIDS 19: 586-589 [Abstract] [Full text]  
• Werb, D., Kerr, T., Small, W., Li, K., Montaner, J., Wood, E. (2008). HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies. J Public Health (Oxf) 30: 126-132 [Abstract] [Full text]  
• Vescio, M F, Longo, B, Babudieri, S, Starnini, G, Carbonara, S, Rezza, G, Monarca, R (2008). Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J. Epidemiol. Community Health 62: 305-313 [Abstract] [Full text]  
• Buck, J. M., Morrow, K. M., Margolis, A., Eldridge, G., Sosman, J., MacGowan, R., Binson, D., Kacanek, D., Flanigan, T. P., The Project START Study Group, (2006). Hepatitis B Vaccination in Prison: The Perspectives of Formerly Incarcerated Men. J Correct Health Care 12: 12-23 [Abstract]  
• Khan, A. J., Simard, E. P., Bower, W. A., Wurtzel, H. L., Khristova, M., Wagner, K. D., Arnold, K. E., Nainan, O. V., LaMarre, M., Bell, B. P. (2005). Ongoing Transmission of Hepatitis B Virus Infection Among Inmates at a State Correctional Facility. AJPH 95: 1793-1799 [Abstract] [Full text]  
• Champion, J. K., Taylor, A., Hutchinson, S., Cameron, S., McMenamin, J., Mitchell, A., Goldberg, D. (2004). Incidence of Hepatitis C Virus Infection and Associated Risk Factors among Scottish Prison Inmates: A Cohort Study. Am J Epidemiol 159: 514-519 [Abstract] [Full text]  
• Long, J., Allwright, S., Barry, J., Reynolds, S. R., Thornton, L., Bradley, F., Parry, J. V, Bird, S. M (2001). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey Commentary: efficient research gives direction on prisoners' and the wider public health---except in England and Wales. BMJ 323: 1209-1209 [Abstract] [Full text]  
• Allwright, S., Bradley, F., Long, J., Barry, J., Thornton, L., Parry, J. V (2000). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 321: 78-82 [Abstract] [Full text]  
• Strauss, R. S. (1999). Self-reported Weight Status and Dieting in a Cross-sectional Sample of Young Adolescents: National Health and Nutrition Examination Survey III. Arch Pediatr Adolesc Med 153: 741-747 [Abstract] [Full text]  
• Gore, S.M., Bird, A.G., Cameron, S.O., Hutchinson, S.J., Burns, S.M., Goldberg, D.J. (1999). Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM 92: 25-32 [Abstract] [Full text]  
• van Beek, I., Dwyer, R., Dore, G. J, Luo, K., Kaldor, J. M (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 317: 433-437 [Abstract] [Full text]  
• Nelles, J, Fuhrer, A, Hirsbrunner, H., Harding, T. (1998). Provision of syringes: the cutting edge of harm reduction in prison?. BMJ 317: 270-273 [Full text]  
• Bird, A G., Gore, S. M, Hutchinson, S. J, Lewis, S. C, Cameron, S., Burns, S. (1997). Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. BMJ 315: 21-24 [Abstract] [Full text]  
• Yirrell, D L, Robertson, P, Goldberg, D J, McMenamin, J, Cameron, S, Brown, A J L. (1997). Molecular investigation into outbreak of HIV in a Scottish prison. BMJ 314: 1446-1446 [Abstract] [Full text]  
• Gill, O., Noone, A., Heptonstall, J. (1995). Imprisonment, injecting drug use, and bloodborne viruses. BMJ 310: 275-276 [Full text]